Literature DB >> 16240207

Severe and refractory peptic ulcer disease: the diagnostic dilemma: case report and comprehensive review.

James L Guzzo1, Mona Duncan, Barbara L Bass, Grant V Bochicchio, Lena M Napolitano.   

Abstract

The recognition of Helicobacter pylori infection as a cause of peptic ulcer disease, medical regimens to eradicate the organism, and the widespread use of proton pump inhibition to suppress gastric acid secretion have revolutionized the management of peptic ulcer disease. As a result, successful medical management of peptic ulcer disease has largely supplanted the need for gastric surgery by general surgeons. Surgery is reserved for complications of the disease, refractory disease, or rare causes of ulcer disease such as gastrinoma and Zollinger-Ellison syndrome. In this report, we describe a case of intractable peptic ulcer disease that progressed to gastric outlet obstruction despite maximal medical therapy. We review the diagnostic studies utilized to evaluate the potential etiologies of peptic ulcer disease and the difficulty in diagnosing gastrinoma and Zollinger-Ellison in the setting of potent medical acid suppression therapy.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16240207     DOI: 10.1007/s10620-005-2999-5

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  41 in total

1.  Does fasting serum gastrin predict gastric acid suppression in patients on proton-pump inhibitors?

Authors:  E S Bonapace; R S Fisher; H P Parkman
Journal:  Dig Dis Sci       Date:  2000-01       Impact factor: 3.199

2.  Helicobacter pylori-negative peptic ulcers: frequency and implications for management.

Authors:  J W Freston
Journal:  J Gastroenterol       Date:  2000       Impact factor: 7.527

3.  Zollinger-Ellison syndrome. Clinical presentation in 261 patients.

Authors:  P K Roy; D J Venzon; H Shojamanesh; A Abou-Saif; P Peghini; J L Doppman; F Gibril; R T Jensen
Journal:  Medicine (Baltimore)       Date:  2000-11       Impact factor: 1.889

4.  Meta-analysis: the efficacy, adverse events, and adherence related to first-line anti-Helicobacter pylori quadruple therapies.

Authors:  L A Fischbach; S van Zanten; J Dickason
Journal:  Aliment Pharmacol Ther       Date:  2004-11-15       Impact factor: 8.171

Review 5.  Proton pump inhibitor co-therapy with nonsteroidal anti-inflammatory drugs--nice or necessary?

Authors:  Loren Laine
Journal:  Rev Gastroenterol Disord       Date:  2004

6.  Surgery to cure the Zollinger-Ellison syndrome.

Authors:  J A Norton; D L Fraker; H R Alexander; D J Venzon; J L Doppman; J Serrano; S U Goebel; P L Peghini; P K Roy; F Gibril; R T Jensen
Journal:  N Engl J Med       Date:  1999-08-26       Impact factor: 91.245

Review 7.  Eradication therapy for peptic ulcer disease in Helicobacter pylori positive patients.

Authors:  A Ford; B Delaney; D Forman; P Moayyedi
Journal:  Cochrane Database Syst Rev       Date:  2004-10-18

8.  Maintenance oral pantoprazole therapy is effective for patients with Zollinger-Ellison syndrome and idiopathic hypersecretion.

Authors:  David C Metz; Elaine Soffer; Chris E Forsmark; Byron Cryer; William Chey; Wieslaw Bochenek; Joseph R Pisegna
Journal:  Am J Gastroenterol       Date:  2003-02       Impact factor: 10.864

Review 9.  Challenges in managing NSAID-associated gastrointestinal tract injury.

Authors:  Jay L Goldstein
Journal:  Digestion       Date:  2004       Impact factor: 3.216

10.  High efficacy of 1-week doxycycline- and amoxicillin-based quadruple regimen in a culture-guided, third-line treatment approach for Helicobacter pylori infection.

Authors:  G Cammarota; A Martino; G Pirozzi; R Cianci; G Branca; E C Nista; A Cazzato; O Cannizzaro; L Miele; A Grieco; A Gasbarrini; G Gasbarrini
Journal:  Aliment Pharmacol Ther       Date:  2004-04-01       Impact factor: 8.171

View more
  2 in total

Review 1.  Diagnostic and Treatment Approaches for Refractory Peptic Ulcers.

Authors:  Heung Up Kim
Journal:  Clin Endosc       Date:  2015-07-24

Review 2.  Considerations on risk factors correlated to the occurrence of gastric stump cancer.

Authors:  D N Păduraru; A Nica; D Ion; M Handaric; O Andronic
Journal:  J Med Life       Date:  2016 Apr-Jun
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.